Device Implant Cardio Defib - Icds

Aurora Ev-Icd Mri Surescan

Payments companies reported to CMS as associated with Aurora Ev-Icd Mri Surescan. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$611Kassociated payments (2023-2025)
3,445clinicians with associated payments
1company reporting

By year

2024 $198K
2025 $412K

Payments reported as associated with Aurora Ev-Icd Mri Surescan, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $318K
Cardiovascular Disease $90K
Physician Assistant $25K
Internal Medicine $23K
Interventional Cardiology $22K
Family $20K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Aurora Ev-Icd Mri Surescan

These are the largest totals companies reported as associated with Aurora Ev-Icd Mri Surescan. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Oliver Monfredi Charlottesville, VA Clinical Cardiac Electrophysiology $10,304.90
Gregory Engel E Palo Alto, CA Clinical Cardiac Electrophysiology $6,187.54
Hilton Franqui-Rivera Toa Alta, PR Clinical Cardiac Electrophysiology $5,125.95
Theodore Takata Fort Worth, TX Clinical Cardiac Electrophysiology $4,922.43
John Rogers La Jolla, CA Clinical Cardiac Electrophysiology $4,097.00
Robert Lyons Ypsilanti, MI Surgery $3,998.52
Jose Rodriguez Vega Bayamon, PR Thoracic Surgery (Cardiothoracic Vascular Surgery) $3,710.94
Ali Al Mudamgha East Syracuse, NY Clinical Cardiac Electrophysiology $3,696.42
Anish Amin Columbus, OH Clinical Cardiac Electrophysiology $3,402.20
Suleyka Olivero-Rivera Bayamon, PR Clinical Cardiac Electrophysiology $3,360.73

Prescribed Aurora Ev-Icd Mri Surescan?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.